Squarepoint’s SBC Medical Group SBC Stock Holding History

Squarepoint’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$91.2K	Buy	+18,461	New	+$69.1K	﹤0.01%	4225

Other funds holding SBC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Squarepoint's SBC Position: Q3 2026 in Review

Squarepoint opened a new position in SBC Medical Group (SBC) in Q3 2026: 18,461 shares worth $91.2K. The stake represents ﹤0.01% of the portfolio and ranks #4225 among its holdings.

26 funds tracked by Wall St. Rank hold SBC as of Q3 2026.

Squarepoint held 18,461 shares of SBC Medical Group worth $91.2K as of Q3 2026.
SBC Medical Group was a new Squarepoint position in Q3 2026.
SBC Medical Group made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4225 holding.
26 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.